Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2140

Argenx reports Vyvgart sales streak, bolstered by launch in rare neuro disorder

$
0
0
Argenx’s Vyvgart has beat sales expectations for the eleventh quarter in a row, supported by strong uptake of a subcutaneous version of the drug in its newest indication. Vyvgart made $573 million in the third ...

Viewing all articles
Browse latest Browse all 2140

Trending Articles